[Role of fractional exhaled nitric oxide (FeNO) measurement in the management of asthma with corticosteroids]
Lehtimaki L, Csonka P, Makinen E, Isojarvi J, Hovi SL, Ahovuo-Saloranta A
Record ID 32010001432
Finnish
Original Title:
Uloshengitysilman typpioksidimittauksen merkitys astman glukokortikoidihoidossa
Details
Project Status:
Completed
URL for project:
http://finohta.stakes.fi/EN/research/projects/index.htm
Year Published:
2015
URL for published report:
https://www.ppshp.fi/dokumentit/Kehitys%20ja%20tutkimus%20sislttyyppi/SLL_2014_UloshengitysilmanTyppioksidimittauksenMerkitysAstmanGlukokortikoidihoidossa_VE.pdf#search=nitric
URL for additional information:
https://www.ppshp.fi/dokumentit/Kehitys%20ja%20tutkimus%20sislttyyppi/SLL_2014_UloshengitysilmanTyppioksidimittauksenMerkitysAstmanGlukokortikoidihoidossa_eng.pdf#search=nitric
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Finland
MeSH Terms
- Asthma
- Nitric Oxide
- Fractional Exhaled Nitric Oxide Testing
- Adrenal Cortex Hormones
- Anti-Asthmatic Agents
Contact
Organisation Name:
Finnish Coordinating Center for Health Technology Assessment
Contact Address:
Finnish Office for Health Care Technology Assessment (Finohta)
Contact Name:
.
Contact Email:
fincchta@ppshp.fi
Copyright:
Finnish Office for Health Care Technology Assessment (FinOHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.